MedPath

Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes

Phase 4
Completed
Conditions
Type 2 Diabetes
Interventions
Behavioral: frequency of self monitoring blood glucose
Registration Number
NCT00202033
Lead Sponsor
HealthPartners Institute
Brief Summary

To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.

Detailed Description

To determine the impact of SMBG frequency on blood glucose control in patients receiving systematic diabetes management education through Type 2 Diabetes BASICS at International Diabetes Center.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Type 2 diabetes
  • Treatment with diet and exercise alone or with the addition of 1 or 2 oral agents
  • Enrolled in Type 2 BASICS program
  • A1c between 7.0 and 11%, inclusive
  • Able to understand spoken English
Exclusion Criteria
  • Insulin therapy
  • Unable/unwilling to perform SMBG
  • Participating in another research study
  • Currently performing SMBG >3 times/week

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2frequency of self monitoring blood glucoseonly self monitor blood glucose when fasting
3frequency of self monitoring blood glucoseno self monitoring of blood glucose
1frequency of self monitoring blood glucoseself monitor blood glucose 3 times a day per usual diabetes class curriculum
Primary Outcome Measures
NameTimeMethod
HbA1c2 years
Secondary Outcome Measures
NameTimeMethod
blood glucose testing frequency2 years

Trial Locations

Locations (1)

International Diabetes Center

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath